Definium Therapeutics DFTX Cash Flow Statement (2021-2026)

NASDAQ DFTX
$38.41 +2.24 (+6.19%)
At close: Sep 28, 2026 · 4:00 PM EDT
Reported Financials

Definium Therapeutics Quarterly Cash Flow Statement

Periods 22 quarters
Latest Jun 2026

Definium Therapeutics reported cash from operations of -$52.78M and free cash flow of -$52.78M for the quarter ended Jun 2026, down 78.3% year over year. This cash flow statement covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-17.20M-16.83M-18.50M-16.96M-16.48M-4.90M-19.58M-27.87M-20.45M-21.30M-20.98M-21.81M-22.01M-29.84M-30.33M-40.47M-44.71M-45.37M-57.01M-72.72M
Cash from Operations
-16.78M-7.83M-12.87M-15.13M-9.30M-12.85M-13.33M-13.85M-16.63M-20.56M-16.60M-19.99M-17.19M-25.35M-29.42M-29.60M-29.57M-42.98M-42.63M-52.78M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.80M0.79M0.80M0.80M0.80M0.80M0.80M0.80M0.80M0.80M0.53M
Change in Working Capital
Change in Account Payables
0.69M0.65M-0.84M-2.59M0.10M1.27M0.21M6.26M-0.93M-3.51M1.51M-2.96M-0.53M-0.14M0.26M1.95M3.90M-2.77M1.78M-0.16M
Change in Accured Expenses
-5.47M7.52M0.99M-0.20M-0.17M-1.04M0.70M3.19M-0.15M1.58M-2.70M0.99M1.03M3.79M-1.33M3.01M3.36M0.92M2.99M6.85M
Other Working Capital Changes
-0.87M3.09M-0.92M0.38M-1.30M2.10M-0.91M-0.11M-0.56M1.54M-0.47M1.49M-0.49M3.81M1.38M-3.12M-0.85M2.44M-0.58M0.26M
Investing Activities
Acquisitions
Cash from Investing Activities
-0.03M0.11M-162.46M-39.54M15.41M34.98M42.00M-316.74M
Financing Activities
Other financing activities
0.41M0.04M0.13M0.45M
Change in Capital Stock
Net Equity Issued and Repurchased
-0.00M0.12M0.58M40.86M0.73M0.58M1.27M-1.74M7.42M1.70M2.73M245.57M0.58M0.42M257.85M3.83M801.17M
Misc.
Cash from Financing Activities
0.82M0.13M-0.17M0.59M58.21M0.42M0.58M1.27M17.40M2.59M169.25M10.79M69.35M3.81M1.00M19.65M0.75M245.87M5.31M762.27M
Exchange Rate Effect
4.81M-4.79M-0.04M-0.19M-0.14M0.06M0.01M0.06M0.03M-0.03M-0.02M0.00M-0.01M0.00M-0.01M0.03M-0.02M0.00M0.00M-0.00M
Change in Cash
-11.18M-12.38M-13.07M-14.73M48.78M-12.38M-12.73M-12.51M0.80M-18.00M152.63M-9.20M52.15M-21.54M-190.89M-49.46M-13.43M237.88M4.68M392.75M
Free Cash Flow
-16.78M-7.83M-12.87M-15.13M-9.30M-12.85M-13.33M-13.85M-16.63M-20.56M-16.60M-19.99M-17.19M-25.35M-29.42M-29.60M-29.57M-42.98M-42.63M-52.78M
Net Cash Flow
-15.99M-7.59M-13.03M-14.54M48.91M-12.43M-12.75M-12.57M0.77M-17.97M152.65M-9.20M52.16M-21.54M-190.88M-49.49M-13.41M237.88M4.68M392.75M

Definium Therapeutics Cash Flow Statement API

Pull Definium Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=DFTX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY